Targeting such mechano-regulated pathways, for instance through pharmacological inhibition of FAK or YAP, has already demonstrated therapeutic potential in preclinical cancer models, underscoring the translational value of μg research for the development of anti-metastatic strategies. This evidence concerns the gene PTK2 and cancer.